味の素バイオファーマ・サービスが「CMOリーダーシップ賞」を2つ受賞

March 3, 2022 – Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, received two CMO Leadership Awards in the categories Expertise and Service for Big Pharma.

“We are extremely pleased to be recognized by our partners. Aji Bio-Pharma has continued to invest in new technologies, quality systems, and, most importantly, our people to increase our capabilities and capacities to meet the needs of our valued clients. In doing so, we further contribute to improving and extending the lives of patients with the drugs we produce.” said Nobu Shimba, CEO, Ajinomoto Bio-Pharma Services US.

Established in 2011, the CMO Leadership Awards recognize top outsourcing partners. The awards are presented by Life Science Leader magazine and Industry Standard Research (ISR). The winning CMOs are chosen through impartial market research based on feedback from sponsor companies that utilize outsourcing services. More than 86 contract manufactures were assessed by 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey. Based on ratings of recent outsourced projects provided by sponsors, this experiential feedback is analyzed by sponsor company size to reveal leading CMOs in different performance categories.

Mark Cassidy, CEO, Ajinomoto Bio-Pharma Services EU, stated, “This award is especially meaningful for us as we take great pride in providing personalized service and the expertise to meet our clients’ needs in delivering quality products. For the last 30 years, some of the largest bio-pharma companies have entrusted us to supply product for billions of doses of life saving medicines and thereby realize our mission to help improve the health of humankind.”

“For nearly a decade, these awards have proven most meaningful for biopharma organizations striving to obtain optimal outcomes from their outsourcing activities. Our research arm, Industry Standard Research (ISR), which only surveys drug sponsors who have worked recently with specific CDMOs, ensures the validity of these results. Our winners will be your champions of outsourcing.” Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma.

味の素バイオファーマサービスについて
味の素バイオファーマサービスは、ベルギー、米国、日本、インドに拠点を置く完全統合型の受託開発・製造機関（CDMO）であり、低分子・高分子の原薬（API）および中間体に対し、包括的な開発、cGMP準拠の製造、無菌充填・包装サービスを提供しています。 味の素バイオファーマ・サービスは、Corynex®タンパク質発現技術、オリゴヌクレオチド合成、抗体薬物複合体（ADC）、高活性原薬（HPAPI）、生体触媒、連続フロー製造など、前臨床およびパイロットプログラムから商業生産規模に至るまで、幅広い革新的なプラットフォームと能力を提供しています。 味の素バイオファーマ・サービスは、お客様のニーズに応えるため、高水準の品質とサービスの提供に尽力しています。詳細はこちら：www.AjiBio-Pharma.com